Dr. Ching-Chu Lu is a nuclear medicine physician specializing in molecular imaging and theranostics. He currently serves as Director of the Department of Nuclear Medicine at the National Taiwan University Cancer Center and Assistant Professor at National Taiwan University. His research focuses on functional imaging in endocrine and oncologic diseases, particularly primary aldosteronism and prostate cancer.
Dr. Lu received his M.D. from Taipei Medical University. He later completed a Master’s degree at the Graduate Institute of Health Policy and Management, and a Ph.D. at the Graduate Institute of Epidemiology and Preventive Medicine, both at National Taiwan University. He is board-certified in nuclear medicine and has authored numerous publications in the fields of nuclear medicine, endocrinology, oncology, and cardiovascular research.
He has played a key role in the Taiwan Primary Aldosteronism Study Group (TAIPAI) and serves as a board supervisor of the Society of Nuclear Medicine, Taiwan.
15th August 2025
Time |
Session |
|
15:30
17:00
|
Prostate Cancer
-
Prostate Cancer
-
Focal Therapy in Asia – Is It Prime Time?
-
Primary Radical Prostatectomy in Low Volume Metastatic Prostate Cancer
-
Risk Stratification and Contemporary Management of Biochemical Recurrence
-
The Strategy to Initiate PSMA-Based Therapies for Advanced Prostate Cancer
-
Discussion
TICC - 2F 201BC
|